Peterson EC - Search Results

1

Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats.

Janganati V, Salazar P, Parks BJ, Gorman GS, Prather PL, Peterson EC, Alund AW, Moran JH, Crooks PA, Brents LK. Janganati V, et al. Among authors: peterson ec. Front Pharmacol. 2023 May 9;14:1123261. doi: 10.3389/fphar.2023.1123261. eCollection 2023. Front Pharmacol. 2023. PMID: 37229250 Free PMC article.

2

Short-Term Safety of Repeated Acetaminophen Use in Patients With Compensated Cirrhosis.

McGill MR, James LP, McCullough SS, Moran JH, Mathews SE, Peterson EC, Fleming DP, Tripod ME, Vazquez JH, Kennon-McGill S, Spencer HJ, Dranoff JA. McGill MR, et al. Among authors: peterson ec. Hepatol Commun. 2022 Feb;6(2):361-373. doi: 10.1002/hep4.1810. Epub 2021 Aug 25. Hepatol Commun. 2022. PMID: 34558847 Free PMC article. Clinical Trial.

3

Pharmacokinetics of bleomycin sclerotherapy in patients with vascular malformations.

Mack JM, Peterson EC, Crary SE, Moran JH, Neville K, Pierce CD, Richter GT. Mack JM, et al. Among authors: peterson ec. Pediatr Blood Cancer. 2022 Aug;69(8):e29733. doi: 10.1002/pbc.29733. Epub 2022 Apr 28. Pediatr Blood Cancer. 2022. PMID: 35484878

4

Development and preclinical testing of a high-affinity single-chain antibody against (+)-methamphetamine.

Peterson EC, Laurenzana EM, Atchley WT, Hendrickson HP, Owens SM. Peterson EC, et al. J Pharmacol Exp Ther. 2008 Apr;325(1):124-33. doi: 10.1124/jpet.107.134395. Epub 2008 Jan 11. J Pharmacol Exp Ther. 2008. PMID: 18192498 Free PMC article.

5

Using hapten design to discover therapeutic monoclonal antibodies for treating methamphetamine abuse.

Peterson EC, Gunnell M, Che Y, Goforth RL, Carroll FI, Henry R, Liu H, Owens SM. Peterson EC, et al. J Pharmacol Exp Ther. 2007 Jul;322(1):30-9. doi: 10.1124/jpet.106.117150. Epub 2007 Apr 23. J Pharmacol Exp Ther. 2007. PMID: 17452421

6

The Development and Characterization of an scFv-Fc Fusion-Based Gene Therapy to Reduce the Psychostimulant Effects of Methamphetamine Abuse.

Hay CE, Ewing LE, Hambuchen MD, Zintner SM, Small JC, Bolden CT, Fantegrossi WE, Margaritis P, Owens SM, Peterson EC. Hay CE, et al. Among authors: peterson ec. J Pharmacol Exp Ther. 2020 Jul;374(1):16-23. doi: 10.1124/jpet.119.261180. Epub 2020 Apr 3. J Pharmacol Exp Ther. 2020. PMID: 32245884 Free PMC article.

7

Affinity improvement of a therapeutic antibody to methamphetamine and amphetamine through structure-based antibody engineering.

Thakkar S, Nanaware-Kharade N, Celikel R, Peterson EC, Varughese KI. Thakkar S, et al. Among authors: peterson ec. Sci Rep. 2014 Jan 14;4:3673. doi: 10.1038/srep03673. Sci Rep. 2014. PMID: 24419156 Free PMC article.

8

[No title available]

[No authors listed] [No authors listed] PMID: 35560349

9

Functional and biological determinants affecting the duration of action and efficacy of anti-(+)-methamphetamine monoclonal antibodies in rats.

Laurenzana EM, Hendrickson HP, Carpenter D, Peterson EC, Gentry WB, West M, Che Y, Carroll FI, Owens SM. Laurenzana EM, et al. Among authors: peterson ec. Vaccine. 2009 Nov 23;27(50):7011-20. doi: 10.1016/j.vaccine.2009.09.072. Epub 2009 Oct 1. Vaccine. 2009. PMID: 19800446 Free PMC article.

10

Customizing monoclonal antibodies for the treatment of methamphetamine abuse: current and future applications.

Peterson EC, Gentry WB, Owens SM. Peterson EC, et al. Adv Pharmacol. 2014;69:107-27. doi: 10.1016/B978-0-12-420118-7.00003-2. Adv Pharmacol. 2014. PMID: 24484976 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

183 results

Search Page